We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Drug Designed To Treat Cancers Associated With Epstein–Barr Virus

News   Mar 03, 2021 | Original story from Hong Kong Baptist University

 
Drug Designed To Treat Cancers Associated With Epstein–Barr Virus

Epstein-Barr virus (EBV) stained with Hematoxylin and eosin (HE). Credit: National Cancer Institute

 
 
Advertisement
 

RELATED ARTICLES

All-in-One Test for SARS-CoV-2 Detection and Surveillance Developed

News

A new type of COVID-19 testing strategy could help streamline the process of identifying cases, tracking variants and detecting co-infecting viruses.

READ MORE

Protein Operates in Tandem With Mutation To Spur Lung Cancer Growth

News

Scientists have identified PLK3, a protein that operates in tandem with a specific genetic mutation to spur lung cancer growth and could serve as a therapeutic target to treat the disease.

READ MORE

SARS-CoV-2 Variants From Mink Evade Inhibition by Antibody

News

Researchers have shown that an antibody used for COVID-19 therapy is unable to effectively inhibit SARS-CoV-2 harboring a spike mutation acquired in minks.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE